Ipsen Biopharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Ipsen Biopharmaceuticals's estimated annual revenue is currently $1.4B per year.
- Ipsen Biopharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- Ipsen Biopharmaceuticals has 7137 Employees.
- Ipsen Biopharmaceuticals grew their employee count by 3% last year.
Ipsen Biopharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | VP | Reveal Email/Phone |
2 | Bilingual Executive Assistant to the VP Global Medical Affairs | Reveal Email/Phone |
3 | Associate VP and Head, Due Diligence and Integration | Reveal Email/Phone |
4 | VP | Reveal Email/Phone |
5 | Chief Information Technology Architect, IT Strategy and Transformation | Reveal Email/Phone |
6 | Chief Accountant | Reveal Email/Phone |
7 | Chief Staff to the Chief Medical Officer and Head Global Medical Affairs (CMO/GMA) | Reveal Email/Phone |
8 | Global Drug Product Development, VP and R&D Site Managing Director | Reveal Email/Phone |
9 | Executive Assistant to VP Treasury, Financing & Credit Management and to VP Tax | Reveal Email/Phone |
10 | VP | Reveal Email/Phone |
Ipsen Biopharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 25 | -11% | N/A | N/A |
#2 | $35.8M | 178 | 8% | N/A | N/A |
#3 | $5.4M | 27 | -25% | N/A | N/A |
#4 | $4180M | 14516 | 1% | $550M | N/A |
#5 | $12.5M | 62 | 15% | N/A | N/A |
#6 | $6.7M | 119 | -37% | $199.6M | N/A |
#7 | $9.4M | 47 | 7% | N/A | N/A |
#8 | $10.3M | 51 | 6% | N/A | N/A |
#9 | $106.3M | 529 | 16% | N/A | N/A |
#10 | $15.5M | 77 | 20% | N/A | N/A |
What Is Ipsen Biopharmaceuticals?
Ipsen is a global specialty driven pharmaceutical company with a significant presence in primary care. Ipsen sells more than 20 drugs in over 115 countries, with a direct commercial presence in over 30 countries worldwide. The Group has more than 4,600 employees all over the world.
keywords:N/AN/A
Total Funding
7137
Number of Employees
$1.4B
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Ipsen Biopharmaceuticals News
Corcept Therapeutics; HRA Pharma; Ipsen Biopharmaceuticals. The following geographical regions are included by the market: The scope of the...
Ipsen has been on a deal-making spree the last few weeks, shelling out more than a billion dollars in two separate deals to work on a mid-stage levodopa-induced dyskinesia (LID) candidate and a preclinical BAX inhibitor in several cancers. But on Monday, the company inked i ...
We need to talk about how we're feeling is the theme of World Kidney Cancer Day (WKCD) on 17 June 2021. To support this theme, Ipsen is launching Perspectives Matter; a social media campaign that brings to life the experiences and perspectives of people who have direct experience of kidney cance ...
We need to talk about how we're feeling is the theme of World Kidney Cancer Day (WKCD) on 17 June 2021. To support this theme, Ipsen is launching Perspectives Matter; a social media campaign that brings to life the experiences and perspectives of people who have direct experience of kidney cance ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1710.5M | 8426 | N/A | N/A |
#2 | $3591.9M | 17694 | -1% | N/A |
#3 | $134240M | 98754 | 4% | $30.1B |
#4 | $15640M | 246141 | N/A | N/A |